Serum protein levels of IL-15 increase during experimental S. aureus-induced arthritis and sepsis (19), and we have previously shown that both IL-15 knockout mice and mice treated with a monotherapy of anti-IL-15 antibodies (aIL-15ab) developed a less destructive S. aureus-induced arthritis than control groups (19). This evidence concerns the gene IL15 and arthritic joint disease.